Invention Grant
- Patent Title: Rifaximin derivative and uses thereof
-
Application No.: US15155733Application Date: 2016-05-16
-
Publication No.: US09725466B2Publication Date: 2017-08-08
- Inventor: Pam Golden , Mohammed A. Kabir , Giuseppe Claudio Viscomi , Manuela Campana , Donatella Confortini , Miriam Barbanti
- Applicant: Salix Pharmaceuticals, Inc. , Alfa Wasserman S.P.A.
- Applicant Address: US NJ Bridgewater IT Bologna
- Assignee: Salix Pharmaceuticals, Ltd,Alfa Wassermann S.P.A.
- Current Assignee: Salix Pharmaceuticals, Ltd,Alfa Wassermann S.P.A.
- Current Assignee Address: US NJ Bridgewater IT Bologna
- Agency: McCarter & English, LLP
- Agent Jonathan M. Sparks; Michael J. DeGrazia
- Main IPC: C07D491/22
- IPC: C07D491/22 ; C07D498/22 ; A61K31/437 ; A61K45/06
Abstract:
25-desacetyl rifaximin or a pharmaceutically acceptable salt thereof is provided. Methods of treatment of bowl related disorders using isolated and/or purified 25-desacetyl rifaximin or a pharmaceutically acceptable salt thereof are also provided.
Public/Granted literature
- US20160257700A1 RIFAXIMIN DERIVATIVE AND USES THEREOF Public/Granted day:2016-09-08
Information query
